Ann: MD Update to AGM , page-3

I'm still mulling on whether to dip my toes in. They seem to have turned things around by discontinuing their underperforming divisions, but I am concerned about the falling sales of the Celebrity Slim range. Obviously sales will increase with the improved distribution of Celebrity Slim to every Coles, Woolies, and Target etc rather than from just Priceline, but how much and is it sustainable?

I like the contract manufacturing for large of global pharmaceutical companies and I think could be very good for them, and particularly, I think commissioning their new dairy protein fractionation plant in South Australia could be a game changer, with a booming commodity price (lactoferrin), which they describe as "blue sky potential."

All I have seen is a 7.4c EPS forecast from a broker, which insinuates 56c on current P/E but not sure how credible it is, and, as you said, they provide no guidance. But they do state they expect $6.5m in increased revenue, and "expect considerable growth in FY14". I've come to respect your opinions and posts on other quality stocks (ALU, CAJ, VTG) and generally agree with your sentiments, hence I'd be interested to know your thoughts vfrioni on where you think this company could be headed, and whether it could reach the prices seens a few years ago. Thanks in advance